New treatment option for Bariatric Surgery Candidate
Official title The Effect of Exercise in Patients Awaiting Bariatric Surgery
ClinicalTrials.gov ID: NCT05235945
What this study is testing
- What it's testing
- The aim of this project is to understand the impact of a four week preoperative exercise programme on fitness and metabolic rate and weight before surgery. A multi-site randomised trial sponsored by UCL, recruiting patients awaiting bariatric surgery for obesity at University College London Hospital (UCLH), Whittington Health NHS Trust, or Homerton University Hospital NHS Foundation Trust.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Adults, aged 18 and above.
- Patients enrolled in the UCLH, Homerton or Whittington Hospitals bariatric surgery program with BMI \> 30 kg/m2
- ≤5 % variation in body weight over preceding 3 months.
- Willing and able to comply with the trial protocol.
- Willing and able to provide written informed consent
You likely can't join if
- Pregnant or lactating mothers.
- Weight over 180 kg (due to weight restrictions of equipment used).
- Current use of betablockade.
- Concurrent participation in other clinical intervention trial.
- Clinically significant medical co-morbidities (e.g. uncontrolled hypertension, unstable cardiovascular disease) that could place at risk of an...
- History of atrial fibrillation, unstable angina, acute coronary syndrome, congestive heart failure New York Heart Association class III-IV within the...
See the full eligibility criteria
- Adults, aged 18 and above.
- Patients enrolled in the UCLH, Homerton or Whittington Hospitals bariatric surgery program with BMI \> 30 kg/m2
- ≤5 % variation in body weight over preceding 3 months.
- Willing and able to comply with the trial protocol.
- Willing and able to provide written informed consent
- Male or Female
- Pregnant or lactating mothers.
- Weight over 180 kg (due to weight restrictions of equipment used).
- Current use of betablockade.
- Concurrent participation in other clinical intervention trial.
- Clinically significant medical co-morbidities (e.g. uncontrolled hypertension, unstable cardiovascular disease) that could place at risk of an adverse response to exercise.
- History of atrial fibrillation, unstable angina, acute coronary syndrome, congestive heart failure New York Heart Association class III-IV within the preceding 12 months.
The study team makes the final eligibility decision.
Where it's taking place
- London, United Kingdom
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include London, United Kingdom. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.